2TZ logo

Tianjin Pharmaceutical Da Ren Tang Group DB:2TZ Stock Report

Last Price

€2.04

Market Cap

€2.8b

7D

3.0%

1Y

n/a

Updated

22 Dec, 2024

Data

Company Financials +

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

DB:2TZ Stock Report

Market Cap: €2.8b

2TZ Stock Overview

Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. More details

2TZ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance2/6
Financial Health5/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tianjin Pharmaceutical Da Ren Tang Group
Historical stock prices
Current Share PriceCN¥2.04
52 Week HighCN¥2.16
52 Week LowCN¥1.96
Beta0.80
1 Month Change-2.95%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-5.45%

Recent News & Updates

Recent updates

Shareholder Returns

2TZDE PharmaceuticalsDE Market
7D3.0%-2.5%-2.6%
1Yn/a-15.6%6.9%

Return vs Industry: Insufficient data to determine how 2TZ performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 2TZ performed against the German Market.

Price Volatility

Is 2TZ's price volatile compared to industry and market?
2TZ volatility
2TZ Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 2TZ's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 2TZ's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19814,619n/awww.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Fundamentals Summary

How do Tianjin Pharmaceutical Da Ren Tang Group's earnings and revenue compare to its market cap?
2TZ fundamental statistics
Market cap€2.83b
Earnings (TTM)€122.47m
Revenue (TTM)€1.06b

26.6x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2TZ income statement (TTM)
RevenueCN¥8.04b
Cost of RevenueCN¥4.30b
Gross ProfitCN¥3.74b
Other ExpensesCN¥2.81b
EarningsCN¥932.37m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.21
Gross Margin46.50%
Net Profit Margin11.60%
Debt/Equity Ratio19.8%

How did 2TZ perform over the long term?

See historical performance and comparison

Dividends

4.0%

Current Dividend Yield

106%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 12:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
Chengzhi ChenCGS International
Shanshan LiChina Merchants Securities Co. Ltd.